NDT Advance Access published online on September 19, 2007
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfm597
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dialysis in Israel, 1989–2005—time trends and international comparisons
1Braun School of Public Health and Community Medicine, Hebrew University-Hadassah, and 2Department of Health Information and Computer Services, Ministry of Health, Jerusalem, Israel
Correspondence and offprint requests to: Ronit Calderon-Margalit, MD, MPH, Braun School of Public Health and Community Medicine, Hebrew University-Hadassah, POB 12272, Jerusalem 91120, Israel. Email: ronitc{at}ekmd.huji.ac.il
 |
Abstract |
|---|
Background. A universal increase in the incidence of renal replacement therapy (RRT) was reported in developed countries during the 1990s, especially among the elderly and diabetic patients. We studied trends in RRT incidence and mortality in Israel between 1989 and 2001–2005.
Methods. The end-stage renal disease (ESRD) registry holds data on all RRT patients in Israel. Age-adjusted incidence rate ratios (RRs) were estimated comparing 2001–2005 with 1989. We compared incidence data between Israel and elsewhere using standardized incidence ratios (SIRs). Survival analysis was conducted by the Kaplan–Meier method and Cox's proportional hazards regression was used to compare survival of diabetic with non-diabetic ESRD patients.
Results. The mean incidence rates per million population increased from 99 in 1989–1991 to 179 in 2003–2005. In 2000, Israel was the second leading country for incidence of RRT.
Age-adjusted incidence rates increased by 67% [95% confidence interval (CI): 49–87%], from 1989 to 2001, but the trend was attenuated between 2002 and 2005. The increase in incidence was positively associated with age, the largest increase being among the elderly aged 
75 years (RR: 3.18, 95%CI: 2.72–3.70). Diabetes accounted for 41% of RRT in 2001 vs only 19% in 1989. There was no increase in 1-year survival between the beginning and the end of the study period. Patients with diabetes-associated RRT had 57% increased risk of 1-year mortality (adjusted HR: 1.57 95% CI: 1.51–1.63).
Conclusions. Despite a similar proportion of RRT attributed to diabetes in Israel and other countries, the age-adjusted incidence in Israel is considerably higher than most countries.
Keywords: end-stage renal disease; incidence; renal replacement therapy; secular trends; survival
Received for publication: 10. 4.07
Accepted in revised form: 1. 8.07